Home | Publications | Country | Europe (West) | France place holder
place holder place holder

France

Smoking Cessation Aids in France


Publication Date   January 2006
Publisher   Euromonitor International
Product Type   Report
Pages   46
ISBN Number   not applicable
Product Code   EUR298
Ask a question about this product?

Price £450.00

approximately: $671 | €536

Summary


Smoking Cessation Aids in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (1999-2004), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2009 illustrate how the market is set to change.

Product coverage: NRT gum, NRT patches, NRT inhalators, other

Data coverage: market sizes (historic and forecasts), company shares, brand shares

Why buy this report?
  • Get a detailed picture of the smoking cessation aids industry
  • Pinpoint growth sectors and trends and identify factors driving change
  • Understand the competitive environment, the market's major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop

Content


Smoking Cessation Aids in France

1. EXECUTIVE SUMMARY

2. OPERATING ENVIRONMENT

2.1 OTC Registration and Classification
2.2 Vitamins & Dietary Supplements Registration and Classification
2.3 Advertising
2.4 Packaging and Labelling
2.5 Distribution
2.6 De-listing or De-reimbursement
2.7 Traditional Remedies
2.8 Homeopathy
2.9 Generics
Table 1 Share of Generics: % of all Medicines Sold 2000-2004
2.10 Consumer Expenditure on Health Goods and Medical Services
Table 2 Consumer Expenditure on Health Goods and Medical Services 1999-2004
2.11 Life Expectancy
Table 3 Life Expectancy at Birth 1999-2004

3. OTC HEALTHCARE SALES

3.1 Market Performance
Table 4 Sales of OTC Healthcare by Sector: Value 1999-2004
Table 5 Sales of OTC Healthcare by Sector: % Value Growth 1999-2004
3.2 Switches
Summary 1 OTC Healthcare Switches 2003-2004
3.3 Key Trends and Developments
3.4 Competitive Environment
Table 6 OTC Healthcare Company Shares 2001-2004
Table 7 OTC Healthcare Brand Shares 2001-2004
3.5 Leading Company Profiles - Arkopharma SA
Summary 2 Arkopharma SA Operational Indicators 2004
Table 8 Arkopharma SA Shares of OTC Healthcare by Subsector 2001-2004
3.6 Leading Company Profiles - Boehringer Ingelheim France SAS
Summary 3 Boehringer Ingelheim France SAS Operational Indicators 2005
Table 9 Boehringer Ingelheim France SAS Shares of OTC Healthcare by Subsector 2001-2004
3.7 Leading Company Profiles - Laboratoires Martin-Johnson & Johnson-MSD SAS
Summary 4 Laboratoires Martin Johnson & Johnson Operational Indicators 2005
Table 10 Laboratoires Martin-Johnson & Johnson-MSD SAS Shares of OTC Healthcare by Subsector 2001-2004
3.8 Leading Company Profiles - Pierre Fabre SA, Laboratoires
Summary 5 Pierre Fabre SA, Laboratoires Operational Indicators 2005
Summary 6 Pierre Fabre SA, Laboratoires: Production Statistics 2005
Table 11 Pierre Fabre SA, Laboratoires Shares of OTC Healthcare by Subsector 2001-2004
3.9 Leading Company Profiles - Laboratoires Juva Sant
Summary 7 Laboratoires Juva Sant Operational Indicators 2005
Summary 8 Laboratoires Juva Sant: Production Statistics 2005
Table 12 Juva Sant, Laboratoires Shares of OTC Healthcare by Subsector 2001-2004
3.10 Leading Company Profiles - Laboratoires Roche Nicholas SAS
Summary 9 Laboratoires Roche Nicholas SAS Operational Indicators 2003
Summary 10 Laboratoires Roche Nicholas SAS: Production Statistics 2003
Table 13 Laboratoires Roche Nicholas SAS Shares of OTC Healthcare by Subsector 2001-2004
3.11 Leading Company Profiles - Pfizer Sant Grand Public
Summary 11 Pfizer Sant Grand Public Operational Indicators 2005
Table 14 Pfizer Sant Grand Public Shares of OTC Healthcare by Subsector 2001-2004
3.12 Leading Company Profiles - Laboratoires UPSA
Summary 12 UPSA, Laboratoires Operational Indicators 2005
Table 15 UPSA, LaboratoiresShares of OTC Healthcare by Subsector 2001-2004
3.13 Leading Company Profiles - Sanofi-Synthlabo France SA
Summary 13 Sanofi-Aventis France Operational Indicators 2004
Table 16 Sanofi-Synthlabo France SA Shares of OTC Healthcare by Subsector 2001-2004
3.14 Leading Company Profiles - Thraplix SA
Summary 14 Thraplix SA Operational Indicators 2005
Table 17 Thraplix SA Shares of OTC Healthcare by Subsector 2001-2005
3.15 Retail Distribution
Table 18 Sales of OTC Healthcare by Distribution Format: % Analysis 1999/2004
Table 19 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2004
3.16 Retailer Activity and Private Label Trends
Table 20 Penetration of Private Label by Sector 2001-2004
3.17 Forecast Market Performance
Table 21 Forecast Sales of OTC Healthcare by Sector: Value 2004-2009
Table 22 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2004-2009

4. SMOKING CESSATION AIDS SALES

4.1 Number of Smokers
Table 23 Number of Smokers by Gender 1999-2004
4.2 Sector Performance
Table 24 Sales of Smoking Cessation Aids by Subsector: Value 1999-2004
Table 25 Sales of Smoking Cessation Aids by Subsector: % Value Growth 1999-2004
Table 26 Smoking Cessation Aids Company Shares 2001-2004
Table 27 Smoking Cessation Aids Brand Shares 2001-2004
Table 28 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2004-2009
Table 29 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2004-2009
4.3 New Product Developments
Summary 15 Smoking Cessation Aids: New Product Launches 2003-2004

5. OTHER OTC

6. DEFINITIONS